Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microrna reduces growth and metastasis of B16BL6 melanoma cells

Hiroki Ozawa, Yoshiko Sonoda, Takaharu Suzuki, Naomi Yoshida-Hoshina, Megumi Tago, Tadashi Kasahara

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Proteolipid protein 2 (PLP2) promotes the metastasis of B16F10 cells in an experimental metastasis model. However, the effect of PLP2 on spontaneous metastasis has yet to be demonstrated, and whether PLP2 may become a new therapeutic target for malignant tumors is as yet unknown. In this study, PLP2 or focal adhesion kinase (FAK) microRNA-based short hairpin RNAs (miRNAs) were used as target molecules to specifically reduce the expression of PLP2 or FAK in B16BL6 cells. In vitro, the knockdown of PLP2 or FAK significantly inhibited cell proliferation, adhesion, migration and invasion. In a spontaneous metastatic tumor model using a footpad injection, the knockdown of PLP2 or FAK markedly inhibited the proliferation of the primary tumor and prevented tumor cells from invading the popliteal lymph nodes. The results indicate that downregulation of PLP2 or FAK may improve outcomes of malignant tumor therapy.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalOncology Letters
Volume3
Issue number1
DOIs
Publication statusPublished - 2012 Jan

Fingerprint

Focal Adhesion Kinase 2
Proteolipids
MicroRNAs
Melanoma
Neoplasm Metastasis
Growth
Proteins
Neoplasms
Cell Adhesion
Small Interfering RNA
Theoretical Models
Down-Regulation
Lymph Nodes
Cell Proliferation

Keywords

  • B16BL6
  • Focal adhesion kinase
  • Melanoma
  • Metastasis
  • Proteolipid protein 2
  • SiRNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microrna reduces growth and metastasis of B16BL6 melanoma cells. / Ozawa, Hiroki; Sonoda, Yoshiko; Suzuki, Takaharu; Yoshida-Hoshina, Naomi; Tago, Megumi; Kasahara, Tadashi.

In: Oncology Letters, Vol. 3, No. 1, 01.2012, p. 19-24.

Research output: Contribution to journalArticle

Ozawa, Hiroki ; Sonoda, Yoshiko ; Suzuki, Takaharu ; Yoshida-Hoshina, Naomi ; Tago, Megumi ; Kasahara, Tadashi. / Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microrna reduces growth and metastasis of B16BL6 melanoma cells. In: Oncology Letters. 2012 ; Vol. 3, No. 1. pp. 19-24.
@article{58820c8d6f3d418d8110086e9c6b529f,
title = "Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microrna reduces growth and metastasis of B16BL6 melanoma cells",
abstract = "Proteolipid protein 2 (PLP2) promotes the metastasis of B16F10 cells in an experimental metastasis model. However, the effect of PLP2 on spontaneous metastasis has yet to be demonstrated, and whether PLP2 may become a new therapeutic target for malignant tumors is as yet unknown. In this study, PLP2 or focal adhesion kinase (FAK) microRNA-based short hairpin RNAs (miRNAs) were used as target molecules to specifically reduce the expression of PLP2 or FAK in B16BL6 cells. In vitro, the knockdown of PLP2 or FAK significantly inhibited cell proliferation, adhesion, migration and invasion. In a spontaneous metastatic tumor model using a footpad injection, the knockdown of PLP2 or FAK markedly inhibited the proliferation of the primary tumor and prevented tumor cells from invading the popliteal lymph nodes. The results indicate that downregulation of PLP2 or FAK may improve outcomes of malignant tumor therapy.",
keywords = "B16BL6, Focal adhesion kinase, Melanoma, Metastasis, Proteolipid protein 2, SiRNA",
author = "Hiroki Ozawa and Yoshiko Sonoda and Takaharu Suzuki and Naomi Yoshida-Hoshina and Megumi Tago and Tadashi Kasahara",
year = "2012",
month = "1",
doi = "10.3892/ol.2011.422",
language = "English",
volume = "3",
pages = "19--24",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Knockdown of proteolipid protein 2 or focal adhesion kinase with an artificial microrna reduces growth and metastasis of B16BL6 melanoma cells

AU - Ozawa, Hiroki

AU - Sonoda, Yoshiko

AU - Suzuki, Takaharu

AU - Yoshida-Hoshina, Naomi

AU - Tago, Megumi

AU - Kasahara, Tadashi

PY - 2012/1

Y1 - 2012/1

N2 - Proteolipid protein 2 (PLP2) promotes the metastasis of B16F10 cells in an experimental metastasis model. However, the effect of PLP2 on spontaneous metastasis has yet to be demonstrated, and whether PLP2 may become a new therapeutic target for malignant tumors is as yet unknown. In this study, PLP2 or focal adhesion kinase (FAK) microRNA-based short hairpin RNAs (miRNAs) were used as target molecules to specifically reduce the expression of PLP2 or FAK in B16BL6 cells. In vitro, the knockdown of PLP2 or FAK significantly inhibited cell proliferation, adhesion, migration and invasion. In a spontaneous metastatic tumor model using a footpad injection, the knockdown of PLP2 or FAK markedly inhibited the proliferation of the primary tumor and prevented tumor cells from invading the popliteal lymph nodes. The results indicate that downregulation of PLP2 or FAK may improve outcomes of malignant tumor therapy.

AB - Proteolipid protein 2 (PLP2) promotes the metastasis of B16F10 cells in an experimental metastasis model. However, the effect of PLP2 on spontaneous metastasis has yet to be demonstrated, and whether PLP2 may become a new therapeutic target for malignant tumors is as yet unknown. In this study, PLP2 or focal adhesion kinase (FAK) microRNA-based short hairpin RNAs (miRNAs) were used as target molecules to specifically reduce the expression of PLP2 or FAK in B16BL6 cells. In vitro, the knockdown of PLP2 or FAK significantly inhibited cell proliferation, adhesion, migration and invasion. In a spontaneous metastatic tumor model using a footpad injection, the knockdown of PLP2 or FAK markedly inhibited the proliferation of the primary tumor and prevented tumor cells from invading the popliteal lymph nodes. The results indicate that downregulation of PLP2 or FAK may improve outcomes of malignant tumor therapy.

KW - B16BL6

KW - Focal adhesion kinase

KW - Melanoma

KW - Metastasis

KW - Proteolipid protein 2

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=84855219134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855219134&partnerID=8YFLogxK

U2 - 10.3892/ol.2011.422

DO - 10.3892/ol.2011.422

M3 - Article

AN - SCOPUS:84855219134

VL - 3

SP - 19

EP - 24

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -